CBFB and breast carcinoma: This data is complimented by results from the METABRIC study [24], where CBFB was shown to be altered in 14% of the 2433 breast cancer cases investigated (Figure 1), as well as in 13% of primary breast cancer cases in the TCGA Firehose legacy dataset, and in 5% of metastatic breast cancer samples analyzed in the study by Li et al. [22,23,176,177,178].